MedTrace Logo

Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer

NCT00766454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1104

Last updated 2017-08-01

No results posted yet for this study

Summary

RATIONALE: Studying samples of urine and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This study is looking at urine and blood samples in women with newly diagnosed breast cancer.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

mutation analysis

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

OTHER

medical chart review

OTHER

questionnaire administration

PROCEDURE

evaluation of cancer risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Steven A. Akman, MD · Wake Forest University Health Sciences

Eligibility

Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-11-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766454 on ClinicalTrials.gov